Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06511141 · ClinicalTrials.gov registry record · NA
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
A NA study of Prostate Cancer and Overactive Bladder, sponsored by Axonics.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 19
- Study locations
NCT06511141 is a NA study of Prostate Cancer and Overactive Bladder that is actively recruiting participants, run by Axonics. The registered enrollment target is 150 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (75% lower). The trial reports 19 study locations across 14 states.
The verdict
NCT06511141, a NA study of Prostate Cancer and Overactive Bladder, is actively recruiting participants, sponsored by Axonics.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 19
- Study locations
Study Summary
To assess the post-market clinical outcomes of the Axonics SNM System for treatment of overactive bladder in male patients.
Conditions Studied
Interventions
- DEVICE Axonics SNM System
Study Locations (19)
Alabama
- University of Alabama at Birmingham - Birmingham
- Urology Associates - Fairhope
California
- El Camino Health - Mountain View
- Tri Valley Urology - Murrieta
Florida
- University of Miami - Miami
- Advanced Urology Institute - Oxford
Louisiana
- Louisiana State University - New Orleans
- WK Clinical Research - Shreveport
Texas
- Urology Partners of North Texas (UPNT) - Arlington
- Texas Oncology - Houston
Arizona
- Mayo Clinic - Scottsdale
Maryland
- Anne Arundel Urology - Annapolis
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2024-10-22 |
| Est. Completion | 2028-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06511141
The ClinicalTrials.gov registry entry for NCT06511141 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (75% lower). The listed sponsor is Axonics, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Axonics SNM System is the first listed.
NCT06511141 reports 19 study locations spanning 14 distinct geographic areas - top geographies include Alabama, California, Florida.
Frequently Asked Questions
What is clinical trial NCT06511141 about?
NCT06511141 is a clinical study titled "Sacral Neuromodulation for Male Overactive Bladder (MOAB)". To assess the post-market clinical outcomes of the Axonics SNM System for treatment of overactive bladder in male patients.
What is the current status of trial NCT06511141?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2024-10-22. Estimated completion is 2028-03.
What conditions does trial NCT06511141 study?
This clinical trial studies the following conditions: Prostate Cancer, Overactive Bladder, Benign Prostatic Hyperplasia, Prostatectomy, Urinary Frequency.
What interventions are being tested in trial NCT06511141?
The interventions under investigation include: Axonics SNM System (DEVICE).
Who is sponsoring clinical trial NCT06511141?
This trial is sponsored by Axonics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06511141 being conducted?
This trial has 19 study locations across Alabama, Arizona, California, Florida, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
RECRUITING · NA
-
Diffusion Basis Spectrum Imaging of the Prostate
RECRUITING · NA
-
Micro-UltraSound In Cancer - Active Surveillance
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
SBRT Boost for Unfavorable Prostate Cancer'
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.